RECORD OF PROCEEDINGS
PHYSICAL DISABILITY BOARD OF REVIEW
BRANCH OF SERVICE: NAVY
NAME: XXXX
CASE NUMBER: PD1200250 SEPARATION DATE: 20040611
BOARD DATE: 20121031
SUMMARY OF CASE: Data extracted from the available evidence of record reflects that this
covered individual (CI) was an active duty Naval Officer, LCDR/0-4 (9640, Op Intel), medically
separated for Factor II Mutation. The CI developed a blood clot in his right calf after a
prolonged air flight and was determined to have a congenital blood disorder (Factor II
Mutation) which can cause excessive blood clotting. He was treated with long term
anticoagulation (Coumadin) and referred for a Medical Evaluation Board (MEB). The MEB
forwarded Factor II Mutation as medically unacceptable IAW SECNAVIST 1850.4E citing risks of
hemorrhage while anticoagulated during military service. The MEB forwarded no other
conditions for Informal Physical Evaluation Board (IPEB) adjudication. The IPEB adjudicated the
condition as unfitting, rated 0%, with application of the Veteran’s Affairs Schedule for Rating
Disabilities (VASRD). The CI appealed to the Formal PEB (FPEB), but withdrew his appeal, when
the disability rating was adjusted to 10% by an interim reconsideration PEB. The CI made no
further appeals and was medically separated with a 10% disability rating.
CI CONTENTION: The CI states: “The 10% rate was based on the assumptions that: 1.) onetime
localized event, 2.) due to aggravating circumstance, 3.) not requiring lifelong meds. All three
assumptions were proved false in July 2010 when I was admitted to ICU with multiple
pulmonary emboli (illegible) aggravating reason & requiring lifelong meds. A full review
package with 12 enclosures was submitted to the Veterans Administration in Seattle on 6
March. The case review is under my social sn. [sic] All assumptions of Med Review Board, and
review by hematol/oncol [sic] clinic Bethesda 8 April 2004 proved false by medical events of
July/August 2010. 3 days in ICU, easily could have died, lifelong medication.”
SCOPE OF REVIEW: The Board wishes to clarify that the scope of its review as defined in the
Department of Defense Instruction (DoDI) 6040.44 (Enclosure 3, paragraph 5.e.(2) is limited to
those conditions which were determined by the PEB to be specifically unfitting for continued
military service; or, when requested by the CI, those condition(s) “identified but not
determined to be unfitting by the PEB.” The ratings for unfitting conditions will be reviewed in
all cases. Any conditions or contention not requested in this application, or otherwise outside
the Board’s defined scope of review, remain eligible for future consideration by the Board for
Correction of Naval Records.
RATING COMPARISON:
VA (3 Mos. Post-Separation) – All Effective Date 20040612
Condition
Code
Rating
Deep Venous Thrombosis
w/Associated Factor II Mutation
S/P Ventral Hernia Repair…..
7121
7338
10%*
0%**
0% X 0 / Not Service-Connected x 0
Exam
20040909
&
20040922
20080327
20040909
Service Recon PEB – Dated 20031104
Condition
Code
Rating
Factor II Mutation
7121
10%
↓No Additional MEB/PEB Entries↓
Combined: 10%
* Continued on VARD 20080919
**Added by VARD of 20080919 effective the day after separation.
Combined: 10%
ANALYSIS SUMMARY: The Disability Evaluation System (DES) is responsible for maintaining a fit
and vital fighting force. While the DES considers all of the member's medical conditions,
compensation can only be offered for those medical conditions that cut short a member’s
career, and then only to the degree of severity present at the time of final disposition. The DES
has neither the role nor the authority to compensate members for anticipated future severity
or potential complications of conditions resulting in medical separation nor for conditions
determined to be service-connected by the Department of Veteran Affairs (DVA) but, not
determined to be unfitting by the PEB. However the DVA, operating under a different set of
laws (Title 38, United States Code), is empowered to compensate all service-connected
conditions and to periodically re-evaluate said conditions for the purpose of adjusting the
Veteran’s disability rating should the degree of impairment vary over time. The Board’s role is
confined to the review of medical records and all evidence at hand to assess the fairness of PEB
rating determinations, compared to VASRD standards, based on severity at the time of
separation. The Board has neither the jurisdiction nor authority to scrutinize or render opinions
in reference to the CI’s statements in the application regarding suspected DES improprieties in
the processing of his case or quality of medical care rendered.
Factor II Mutation. The CI developed swelling in his right lower leg after a 13 hour airline flight.
Doppler ultrasound study (US) obtained 12 January 2003 documented a venous clot (DVT) in
the veins of his right lower leg. The CI was treated with an initial course of anticoagulation with
subcutaneous heparin followed by oral anticoagulation with Coumadin without complication.
Extremity swelling had resolved by 16 January 2003 and subsequent US, obtained 17 April 2004
demonstrated complete resolution of the DVT. Coagulation studies identified the Factor II
Mutation condition, and Coumadin therapy was continued with a plan for indefinite treatment.
CI was instructed to wear prescribed compression stockings when on airline flights. At the MEB
exam performed 10 July 2003, approximately a year before separation, the patient was taking
Coumadin without complication. Examination of the lower extremities was recorded as
normal. Three VA Compensation and Pension (C&P) exams were performed, all approximately
3 months after separation. C&P exam, performed on 9 September 2004, the CI reported taking
Coumadin without complication. Examination of the lower extremities revealed no edema,
ulceration or skin changes. Motor and sensory functions and gait were normal. The examiner
noted ‘no conditions which would impact the veteran ability to perform normal daily routine or
work related activities.’ At the C&P hematology examination performed on 22 September
2004, a slight firmness of the right leg, without any evidence of serious overt post phlebitis
syndrome was reported. The C&P vascular exam, performed on 25 September 2004, the CI
reported some aching and swelling in both calves at the end of the day relieved by leg
elevation. He noted exercising and running 3 miles at a time a few times a week without
sequelae. On examination of the lower extremity, no varicosities, skin ulcers, edema, stasis
pigmentation or eczematous changes were noted. The Board directs attention to its rating
recommendation based on the above evidence. Both the PEB and VA rated the left leg
condition 10% code 7121, post phlebitis syndrome. The 10% rating requires intermittent
edema or aching and fatigue in the leg after prolonged standing or walking and symptoms
relieved by elevation or compression therapy. A higher rating 0f 20% requires persistent
edema with or without stasis changes, pigmentation or eczema. The Board unanimously
agreed that there were no findings in the record in evidence which would support the 20%
rating. After due deliberation, considering all of the evidence and mindful of VASRD §4.3
(reasonable doubt), the Board concluded that there was insufficient cause to recommend a
change in the PEB adjudication for the condition.
______________________________________________________________________________
BOARD FINDINGS: IAW DoDI 6040.44, provisions of DoD or Military Department regulations or
guidelines relied upon by the PEB will not be considered by the Board to the extent they were
inconsistent with the VASRD in effect at the time of the adjudication. The Board did not
2 PD1200250
surmise from the record or PEB ruling in this case that any prerogatives outside the VASRD
were exercised. In the matter of the Factor II Mutation condition and IAW VASRD §4.104, the
Board unanimously recommends no change in the PEB adjudication. There were no other
conditions within the Board’s scope of review for consideration.
RECOMMENDATION: The Board, therefore, recommends that there be no recharacterization of
the CI’s disability and separation determination, as follows:
UNFITTING CONDITION
VASRD CODE RATING
7121
COMBINED
10%
10%
Factor II Mutation
The following documentary evidence was considered:
Exhibit A. DD Form 294, dated 20120307, w/atchs
Exhibit B. Service Treatment Record
Exhibit C. Department of Veterans’ Affairs Treatment Record
President
Physical Disability Board of Review
3 PD1200250
MEMORANDUM FOR DIRECTOR, SECRETARY OF THE NAVY COUNCIL
OF REVIEW BOARDS
Subj: PHYSICAL DISABILITY BOARD OF REVIEW (PDBR) RECOMMENDATIONS
Ref: (a) DoDI 6040.44
(b) CORB ltr dtd 7 Nov 12
In accordance with reference (a), I have reviewed the cases forwarded by reference (b), and, for
the reasons provided in their forwarding memorandum, approve the recommendations of the PDBR
that the following individual’s records not be corrected to reflect a change in either characterization
of separation or in the disability rating previously assigned by the Department of the Navy’s
Physical Evaluation Board:
- former USN
- former USN
- former USMC
- former USN
- former USMC
- former USMC
- former USMC
- former USN
Assistant General Counsel
(Manpower & Reserve Affairs)
4 PD1200250
AF | PDBR | CY2011 | PD2011-01024
The conditions of history of deep vein thrombosis of the right and left lower extremities with post-phlebetic syndrome and chronic venous insufficiency as requested for consideration are the residuals that, IAW with the VASRD, should be used to rate the unfitting condition of heterozygous factor V Leiden deficiency and therefore they meet the criteria prescribed in DoDI 6040.44 for Board purview; and are addressed below, as part of the review of the rating for the unfitting condition. ...
AF | PDBR | CY2012 | PD2012 01365
Subsequently after two TDRL periodic exams, the PEB determined the CI’s left lower leg DVT to be stable and unfitting and at this time also determined the CI’s condition to be “post phlebitic syndrome” rated 10%. CI CONTENTION : “Per the findings of my Physical Evaluation Board Proceeding dated 17 Nov 2002, my combined disability rating was rated at 40% category I unfitting conditions. Both the PEBand the VA used the same code:7121, with the PEB rating the condition 10%and the VA rating it...
AF | PDBR | CY2012 | PD2012 01644
The Physical Evaluation Board (PEB) adjudicated the recurrent DVT hypercoagulation syndrome, necessitating life-long anticoagulant therapycondition as an impairment that was EPTS, but subsequently PSA, unfitting, rated 0%, with application of the Veterans Affairs Schedule for Rating Disabilities (VASRD).The PEB also determined the CI’s deafness to be not unfitting and not ratable.The CI made no appeals, and although he was eligible for transfer to the retired reserve he elected to be...
AF | PDBR | CY2014 | PD-2014-02239
The initial VA C&P examination (within the DES Pilot process occurred)dated3 June 2009, during the examination, the examiner noted that the CI was not currently in psychiatric treatment and during brief treatment for his MH symptoms in 2008 he was not hospitalized, was not suicidal and had not required any psychotropic medications.At the VA C&P examination the CI denied being anxious or depressedand the examiner noted the CI was “without signs of ongoing anxiety, depression, or psychosis at...
AF | PDBR | CY2013 | PD2013 00864
SUMMARY OF CASE : Data extracted from the available evidence of record reflects that this covered individual (CI) was an active duty SSGT/E-6 (3381/Food Service Specialist) medically separated for recurrent deep venous thrombosis (DVT).The CI reportedly had his first episode of DVT (a clot in a large leg vein), left lower extremity (LLE), in 1985. The Board determined that the DVT in either leg, in the presence of the requirement for lifelong anti-coagulation, was separately unfitting and...
AF | PDBR | CY2011 | PD2011-00522
As noted above, the PEB found him unfit for military duty, and he was medically separated with 10% disability. All evidence considered, the Board unanimously recommends no change to the PEB’s adjudication of the scoliosis condition. The Board, therefore, has no reasonable basis for recommending any additional unfitting conditions for separation rating.
AF | PDBR | CY2014 | PD-2014-01176
Repeat examination on 27 June 2004 also recorded that there was no edema of the lower extremities. On examination, the left calf and both thighs were tender to touch, and several distended veins were felt on the left lower calf and right upper thigh.A Coumadin Clinic encounter on 9 December 2005, recorded the CI experienced muscle pain when he overdid activities such as standing too long or playing basketball. The CI complained of edema of the lower extremities relieved with elevation on...
AF | PDBR | CY2009 | PD2009-00157
Chronic, Persistent Deep Venous Thrombosis/Recurrent Pulmonary Embolism/Hypercoagulable State requiring chronic use of anticoagulants: The CI served in the U.S. Marine Corps between 1987 and 1991 on active duty. VA treatment records revealed that in January 2009, the CI was admitted for another pulmonary embolism. Either condition alone would require Coumadin use.
AF | PDBR | CY2011 | PD2011-00663
Although the pulmonary scans and pulmonary hypertension were improving, the CI had continued shortness of breath and had a diagnosis of chronic thromboembolic disease. The Physical Evaluation Board (PEB) adjudicated primary hypercoagulable state, on lifelong anticoagulation condition as unfitting (with contributing category II chronic thromboembolic disease and venous stasis) and the CI was rated at 40% and placed on the Temporary Disability Retired List (TDRL). Exhibit C. Department of...
AF | PDBR | CY2009 | PD2009-00559
There were no trophic skin changes or evidence of stasis dermatitis.” Diagnosis was “Postphlebitic syndrome, left lower extremity.” The VA (near entry into TDRL) used essentially the same exams and history as the military and rated the CI’s DVT-related conditions as 7121 (Left Lower Extremity Deep Venous Thrombosis) at 10%, and 6817 (Bilateral Base Pulmonary Emboli Secondary to Deep Venous Thrombosis) at 60%. After due deliberation, considering all of the evidence and mindful of VASRD §4.3...